Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-12-03T19:34:08.900Z Has data issue: false hasContentIssue false
  • English
  • Français

P02.218 Cyamemazine: A revision of its therapeutical anxiolytic profile based on its recently described anti-serotoninergic activity

Published online by Cambridge University Press:  16 April 2020

F. Radat ,
R. Garay ,
F. d'Alché-Birée  and
M. Dib
F. Radat
Affiliation:
Hôp. Pellegrin. Bordeaux: INSERM U400. School of Medicine of Créteil & Lab. Aventis. Montrouge, France
R. Garay
Affiliation:
Hôp. Pellegrin. Bordeaux: INSERM U400. School of Medicine of Créteil & Lab. Aventis. Montrouge, France
F. d'Alché-Birée
Affiliation:
Hôp. Pellegrin. Bordeaux: INSERM U400. School of Medicine of Créteil & Lab. Aventis. Montrouge, France
M. Dib
Affiliation:
Hôp. Pellegrin. Bordeaux: INSERM U400. School of Medicine of Créteil & Lab. Aventis. Montrouge, France

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Information
European Psychiatry , Volume 15 , Issue S2: Congress of the Association of European Psychiatrists , October 2000 , pp. 380s
Copyright
Copyright © European Psychiatric Association 2000
Submit a response

Comments

No Comments have been published for this article.